Tom Brady is once again in the spotlight, this time for his heartfelt connection to his pets. The legendary NFL quarterback recently revealed that his new dog, Junie, is a clone of his late beloved dog, Lua, who passed away nearly two years ago. This groundbreaking development was made possible through the innovative work of the biotech company Colossal Biosciences, which specializes in cloning technology.
In a press release on November 4, Brady expressed deep affection for his animals, stating, “They mean the world to me and my family.” He highlighted the collaboration with Colossal, noting that the non-invasive cloning process involved a simple blood draw from his beloved elderly dog before her passing. This technology has not only given Brady’s family a “second chance” with Junie but also represents significant advancements in the field of pet cloning and conservation.
Brady emphasized the broader implications of this technology, stating, “I am excited how Colossal and Viagen’s tech together can help both families losing their beloved pets while helping to save endangered species.” His words reflect a hopeful sentiment that such advancements in biotech can bring comfort to families dealing with the loss of their cherished pets.
The decision to clone Lua serves as a testament to the bond Brady shares with his pets, a bond that will continue with Junie by his side. As pet cloning technology becomes more refined and accessible, it opens up new avenues for pet owners and the potential for aiding in the conservation of endangered species, showcasing how love and technology can intersect in profoundly meaningful ways.